Please login to the form below

Not currently logged in
Email:
Password:

disease management

This page shows the latest disease management news and features for those working in and with pharma, biotech and healthcare.

Pharma Brand Planners' Blog (Part 4)

Pharma Brand Planners' Blog (Part 4)

2. Social media – fellow physicians sharing their content and views on new publications, launches and disease management trends on platforms such as Twitter, LinkedIn and Facebook.

Latest news

  • Great Expectations Great Expectations

    After all, if patients living 1, 000 miles away have a choice between a surgical procedure or pharmacological management for their disease, isn’t that their personal business? ... Consider the case of John and Maria. They both have Parkinson’s disease

  • Novartis gets breakthrough tag from FDA for sickle cell drug Novartis gets breakthrough tag from FDA for sickle cell drug

    Latest pipeline therapy for painful blood disorder. A monthly antibody drug to treat sickle cell disease, developed by Novartis, has won a coveted breakthrough designation from the FDA as it heads ... Crizanlizumab is just one of a series of new dugs

  • D-day: time to make digital deliver D-day: time to make digital deliver

    while clinical decision support systems and medicines adherence tools are supporting health stakeholders in the management of disease. ... However, if the development of digital tools is to benefit from the undoubted expertise that pharma can bring to

  • Google boosts healthcare business with new hire Google boosts healthcare business with new hire

    disease management. ... care to enable ‘simple and intelligence disease management’.

  • Celgene to launch five new products through to 2020 Celgene to launch five new products through to 2020

    registration trial in this indication – TRUE NORTH – as well as studies in Crohn’s disease. ... Celgene's fundamentals are strong, including robust commercial performance, a broad transformative pipeline, and a strengthened management team,” said

More from news
Approximately 4 fully matching, plus 170 partially matching documents found.

Latest Intelligence

  • Turning learning into action: the challenge of behaviour change Turning learning into action: the challenge of behaviour change

    in relation to the management of disease and healthcare in general.

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    Prof Craig Ritchie. “EPAD is part of a global initiative that will make a fundamental difference to the understanding and management of Alzheimer’s disease in people with very early symptoms, ... Diseases include Alzheimer’s, dementia with Lewy

  • Rare Diseases Day Rare Diseases Day

    On Rare Disease Day in 2019 it is surprising to note that few rare diseases have benefited from the digitisation of condition management and disease information in the same way as ... One in 20 people will be affected by a rare disease at some point in

  • Diagnosed Anywhere Diagnosed Anywhere

    Those distributed healthcare destinations will be powered by new diagnostic tools that help pharmacists act like disease detectives, not just dispensers and injectors. ... They already offer vision and audiology services, active chronic disease care and

  • Behaviour change: what is the buzz all about? Behaviour change: what is the buzz all about?

    Patients have always been a stakeholder in healthcare, but often a ‘sleeping partner’ – the individual with the disease that the healthcare professional would manage. ... Furthermore, it is the patient who ultimately determines if a medication is

More from intelligence
Approximately 0 fully matching, plus 47 partially matching documents found.

Latest appointments

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”. ... Atkins said: “Britten joins our Senior Management team at a

  • Hugh Cole joins Jounce Therapeutics as chief business officer Hugh Cole joins Jounce Therapeutics as chief business officer

    Cole brings over 25 years’ experience in biotech including business development, corporate strategy, R&D, alliance management, commercial planning and execution and corporate leadership. ... He has also held roles for Oscient Pharmaceuticals, The

  • Glyconics appoints CEO Glyconics appoints CEO

    Dr Kam Pooni joins the UK diagnostics firm. UK disease management diagnostics firm Glyconics has appointed Dr Kam Pooni as chief executive officer with immediate effect.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Innovative pricing and contracting options

    For instance, the online-based project launched in 2013 by AstraZeneca and patient engagement firm Exco InTouch, Me&myCOPD, aims to provide chronic obstructive pulmonary disease (COPD) patients with disease information, ... personalised coaching, and

  • A new vision for tackling key illnesses

    Detecting patients at risk of CVD and preventing the disease from occurring will be key to helping the NHS achieve its ambition. ... There will be a big focus on lifestyle improvements for at-risk patients, particularly weight management, as well as

  • Turning learning into action: The challenge of behaviour change

    2. provides a pragmatic adaptation of this model to enable practitioners to understand and intervene in human behaviours in relation to the management of disease and healthcare in general.

  • World Diabetes Day: Interaction and impact of diabetes on mental health

    Moreover, depression and diabetes distress can increase patient risk for mortality, poor disease management, poor quality of life, work absenteeism and other diabetes-related complications [15, 17]. ... and Sreedevi, A., 2013. National recommendations:

  • It’s all about patient outcomes… right?

    A notable study, conducted by the author, sought to understand the disconnect between primary care practitioners (PCPS) and specialists in the management of a chronic inflammatory disease, with particular reference to ... By observing PCPs discussing

More from PMHub
Approximately 0 fully matching, plus 28 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics